title: [Obstacles to medication compliance for patients with glaucoma].
abstract: OBJECTIVE
  Aim of the study was to identify obstacles to medication adherence (compliance) for patients with glaucoma.
  
  
  METHODS
  A prospective case series of structured interviews were conducted in 150 patients with glaucoma. (75 patients treated in the glaucoma out-patient clinic of the Department of Ophthalmology, Medical University, Lublin, Poland and 75 patients treated in regional out-patient clinics). Questionnaire of an anonymous survey, formulated on the basis of the publication: Tsai J.C. et al. "Compliance barriers in glaucoma: a systematic classification", J. Glaucoma. 2003, 12, 393-398.
  
  
  RESULTS
  The results of the survey showed omissions of particular doses of medications in 62.7% of patients from regional outpatient clinics and in 35.3% of patients treated at the Department of Ophthalmology. It was shown that 32.7% of respondents from regional outpatient clinics and 8.7% from the Department of Ophthalmology Glaucoma Clinic declared remaining without antiglaucoma drops for more than one day. As reasons for omissions of single doses of the medications: forgetfulness (54.7%), too many doses of medications (10%) and little knowledge about the disease (10%) were usually pointed. According to the respondents: little knowledge (32%) and financial factors (22%) are the main causes of medications withdrawal for longer time.
  
  
  CONCLUSIONS
  The most common obstacles to medication compliance for patients with glaucoma include: forgetfulness, low level of knowledge about the disease, financial factors and too many doses of the medications. Fewer doses and the presence of a supporting person have a positive influence on compliance.
authors.affiliation: Katedry i Kliniki Okulistyki Uniwersytetu Medycznego w Lublinie. kogoska@o2.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Kowal
authors.forename: Tomasz
authors.initials: T
authors.lastname: Choragiewicz
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Mietlicka
authors.forename: Anna
authors.initials: A
authors.lastname: Wyszyńska
authors.forename: Tomasz
authors.initials: T
authors.lastname: Zarnowski
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000188:drug therapy* / Q000453:epidemiology; D015438:Health Behavior; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011044:Poland / Q000453:epidemiology; D011795:Surveys and Questionnaires; D016312:Treatment Refusal / Q000706:statistics & numerical data; D016903:Drug Monitoring
chemical_list: D000959:Antihypertensive Agents